PHRRF
Price:
$0.172
Market Cap:
$21.16M
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications. Its pipeline also comprises Ketamine Patch that is in Phase I and II clinical trials for treating depression, mental health, complex regional pain syndrome, and pain disorders; and Ketamine Pump, which is in Phase II clinical...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
PHRRF
According to PharmaTher Holdings Ltd.’s latest financial reports and current stock price. The company's current ROE is -102.91%. This represents a change of 325.70% compared to the average of -24.17% of the last 4 quarters.
The mean historical ROE of PharmaTher Holdings Ltd. over the last ten years is -48.84%. The current -102.91% ROE has changed 110.71% with respect to the historical average. Over the past ten years (40 quarters), PHRRF's ROE was at its highest in in the February 2021 quarter at 81.06%. The ROE was at its lowest in in the November 2020 quarter at -143.29%.
Average
-48.84%
Median
-33.89%
Minimum
-133.31%
Maximum
47.72%
Discovering the peaks and valleys of PharmaTher Holdings Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 249.47%
Maximum Annual ROE = 47.72%
Minimum Annual Increase = -860.78%
Minimum Annual ROE = -133.31%
Year | ROE | Change |
---|---|---|
2024 | -133.31% | 12.55% |
2023 | -118.44% | 249.47% |
2022 | -33.89% | -171.02% |
2021 | 47.72% | -860.78% |
The current ROE of PharmaTher Holdings Ltd. (PHRRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-95.22%
5-year avg
-48.84%
10-year avg
-48.84%
PharmaTher Holdings Ltd.’s ROE is greater than Adial Pharmaceuticals, Inc. (-291.06%), greater than TransCode Therapeutics, Inc. (-597.47%), greater than Aditxt, Inc. (-607.01%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Avenue Therapeutics, Inc. (-749.10%), less than Tryp Therapeutics Inc. (0%), less than PsyBio Therapeutics Corp. (131.45%), greater than Awakn Life Sciences Corp. (-867.30%), less than XOMA Corporation (175.85%), greater than Fortress Biotech, Inc. (-19.34%), greater than Checkpoint Therapeutics, Inc. (-226.63%), less than ZIVO Bioscience, Inc. (292.43%), less than Lumos Pharma, Inc. (673.84%), greater than Wesana Health Holdings Inc. (-157.99%), less than BioVaxys Technology Corp. (242.19%), less than GH Research PLC (322.77%), greater than Algernon Pharmaceuticals Inc. (-16.39%), greater than AXIM Biotechnologies, Inc. (-213.50%), less than Regen BioPharma, Inc. (54.15%), less than Regen BioPharma, Inc. (16.82%), less than Mymetics Corporation (16.82%), less than ProtoKinetix, Incorporated (15.72%), greater than null (-87.94%),
Company | ROE | Market cap |
---|---|---|
-291.06% | $6.44M | |
-597.47% | $8.89M | |
-607.01% | $4.28M | |
664.92% | $33.39M | |
-749.10% | $3.15M | |
0% | $5.42M | |
131.45% | $300.75K | |
-867.30% | $3.33M | |
175.85% | $355.58M | |
-19.34% | $47.68M | |
-226.63% | $154.67M | |
292.43% | $68.83M | |
673.84% | $35.87M | |
-157.99% | $171.26K | |
242.19% | $13.83M | |
322.77% | $416.22M | |
-16.39% | $1.32M | |
-213.50% | $1.45M | |
54.15% | $377.63K | |
16.82% | $14.55M | |
16.82% | $303.76K | |
15.72% | $3.94M | |
-87.94% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaTher Holdings Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PharmaTher Holdings Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is PharmaTher Holdings Ltd.'s ROE?
How is the ROE calculated for PharmaTher Holdings Ltd. (PHRRF)?
What is the highest ROE for PharmaTher Holdings Ltd. (PHRRF)?
What is the 3-year average ROE for PharmaTher Holdings Ltd. (PHRRF)?
What is the 5-year average ROE for PharmaTher Holdings Ltd. (PHRRF)?
How does the current ROE for PharmaTher Holdings Ltd. (PHRRF) compare to its historical average?